相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Insights into the Biology of Renal Cell Carcinoma
Lianjie Li et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
EVALUATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC MARKER FOR LOCAL RELAPSE IN EARLY-STAGE BREAST CANCER PATIENTS TREATED WITH BREAST-CONSERVING THERAPY
Meena S. Moran et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
S100A4 and Metastasis A Small Actor Playing Many Roles
Kjetil Boye et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
VEGF and prostatic cancer: a systematic review
Francisco Botelho et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Review: Targeted therapy in renal cancer
Tanya B. Dorff et al.
Therapeutic Advances in Medical Oncology (2009)
Origin of renal cell carcinomas
Manuel Valladares Ayerbes et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies
Ali-Reza Golshayan et al.
FUTURE ONCOLOGY (2008)
S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?
Mikael Schneider et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer
Kai-Xing Ai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Biomarkers in clear cell renal cell carcinoma
Saby George et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Metastasis-associated protein S100A4: Spotlight on its role in cell migration
S. Tarabykina et al.
CURRENT CANCER DRUG TARGETS (2007)
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: Current status and future directions
Brian I. Rini
CLINICAL CANCER RESEARCH (2007)
The metastasis-associated gene S100A4 is a novel target of β-catenin/T-cell factor signaling in colon cancer
Ulrike Stein et al.
GASTROENTEROLOGY (2006)
An update of the S100 nomenclature
Ingo Marenholz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer
SDS Rudland et al.
CLINICAL CANCER RESEARCH (2006)
S100A4, a mediator of metastasis
SC Garrett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma
M Zou et al.
BRITISH JOURNAL OF CANCER (2005)
The metastasis associated protein S100A4: role in tumour progression and metastasis
DM Helfman et al.
BRITISH JOURNAL OF CANCER (2005)
Novel antiangiogenic therapies for renal cell cancer
MS Gordon
CLINICAL CANCER RESEARCH (2004)
Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date
Y Nagashima et al.
PATHOLOGY INTERNATIONAL (2004)
Immunofluorometric assay for the metastasis-related protein S100A4: Release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
K Flatmark et al.
TUMOR BIOLOGY (2004)
Expression of S100A4 and Met: Potential predictors for metastasis and survival in early-stage breast cancer
WY Lee et al.
ONCOLOGY (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Intracellular and extracellular roles of s100 proteins
R Donato
MICROSCOPY RESEARCH AND TECHNIQUE (2003)
Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies
KB Pedersen et al.
BRITISH JOURNAL OF CANCER (2002)
Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer
E Rosivatz et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor
N Ambartsumian et al.
ONCOGENE (2001)
分享论文
